GRFS Grifols SA ADR

Grifols, S.A. (NASDAQ:GRFS) has received a consensus "Hold" rating from five analysts, with an average 1-year target price of $10.00. Analyst opinions are mixed, as some have downgraded the stock while others have upgraded it to a "strong-buy." The company's stock shows a market capitalization of $6.13 billion and institutions like Brandes Investment Partners and Norges Bank have recently increased their stakes.

Grifols, S.A. announced that its joint venture, Grifols Egypt for Plasma Derivatives (GEPD), received European Medicines Agency (EMA) certification for plasma supply. This certification allows GEPD to produce and sell plasma products across Europe and other regions under EMA legislation. The achievement makes Egypt the first country in Africa and the Middle East with a fully integrated plasma collection and processing system meeting international standards.

The State of Wyoming has acquired a new stake in Grifols, S.A. (NASDAQ:GRFS) during the second quarter, purchasing 191,209 shares valued at approximately $1.73 million. This comes amidst varied analyst ratings for GRFS, with a consensus "Hold" rating and a target price of $10.00, though opinions range from "strong-buy" to "strong sell." Other institutional investors like Brandes Investment Partners LP and JPMorgan Chase & Co. also adjusted their holdings in the biotechnology company.

Grizzlyrock Capital LLC has acquired a new stake of 166,000 shares in Grifols, S.A. (NASDAQ:GRFS) valued at approximately $1.50 million, making it their 18th largest holding. Other institutional investors also increased their positions in Grifols. Analysts currently have a "Hold" consensus rating on the stock with a $10.00 price target.

Armistice Capital LLC significantly reduced its stake in Grifols, S.A. (NASDAQ:GRFS) by 21.3% in the second quarter, now holding 7,298,000 shares valued at $65.97 million. Despite this reduction, other institutional investors like Cetera Investment Advisers, Mitsubishi UFJ Asset Management, and Royal Bank of Canada increased their positions, while Groupe la Francaise initiated a new stake. Analyst sentiment for Grifols is mixed, with a consensus "Hold" rating and a target price of $10.00, though individual ratings range from "strong-buy" to "strong-sell."

Norges Bank acquired 1,940,000 shares of Grifols, S.A. ($GRFS) in the second quarter, valued at approximately $17.54 million, bringing their total ownership to 0.28% of the company. Other institutional investors like JPMorgan Chase & Co. also increased their stakes. Despite these acquisitions, analyst sentiment remains "Hold" with an average price target of $10.00, while the stock recently traded around $8.98.